产品编号:D473530
产品规格:25mg
产品价格:面议
| 标准品编号: | D473530 |
| 名称: | (3a'S,4'R,5'R,6a'R)-5'-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-N-[(1R)-2-hydroxy-1-phenylethyl]-5,5-dimethyl-spiro[1,3-dioxane-2,2'(1'H)-pentalene]-4'-carboxamide |
| 别名: | (3a'S,4'R,5'R,6a'R)-5'-((tert-Butyldimethylsilyl)oxy)-N-((S)-2-hydroxy-1-phenylethyl)-5,5-dimethylhexahydro-1'H-spiro[[1,3]dioxane-2,2'-pentalene]-4'-carboxamide |
| CAS号: | 116855-81-3 |
| 分子式: | C₂₈H₄₅NO₅Si |
| 外观: | White Powder |
| 分子量: | 503.75 |
| 溶解性: | DCM, Ethyl Acetate |
| 种类: | Building Blocks; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | (3a'S,4'R,5'R,6a'R)-5'-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-N-[(1R)-2-hydroxy-1-phenylethyl]-5,5-dimethyl-spiro[1,3-dioxane-2,2'(1'H)-pentalene]-4'-carboxamide is an intermediate in the synthesis of Iloprost (I267300),a synthetic analogue of Prostacyclin (PGI2) used to treat pulmonary arterial hypertension (PAH), scleroderma, raynaud's phenomenon and ischemia. |
| 参考文献 | |